Assessment and toxicity. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Liver Cells, Cultured Kidney Cell Line, Tumor Brain Lung Cell Line

Organisms6

Rats, Sprague-Dawley Rats, Inbred F344 Mice, Inbred C57BL Rats, Wistar Dogs Daphnia

Diseases34

Neoplasms Drug-Related Side Effects and Adverse Reactions Radiation Injuries Lung Neoplasms Breast Neoplasms Leukopenia Drug-Induced Liver Injury Body Weight Neutropenia Disease Progression Disease Models, Animal Hematologic Diseases Neurotoxicity Syndromes Thrombocytopenia Nausea Neoplasm Recurrence, Local Neoplasm Metastasis Pain Recurrence Adenocarcinoma Fatigue Gastrointestinal Diseases Chronic Disease Stomatitis Colorectal Neoplasms Abnormalities, Drug-Induced Brain Neoplasms Vomiting Carcinoma, Non-Small-Cell Lung Acute Disease Plant Poisoning Prostatic Neoplasms Poisoning Kidney Diseases

Chemicals and Drugs52

Antineoplastic Agents Cisplatin Fluorouracil Environmental Pollutants Doxorubicin Water Pollutants, Chemical Deoxycytidine Antineoplastic Agents, Phytogenic Biological Markers Paclitaxel Antimetabolites, Antineoplastic Hazardous Substances Cyclophosphamide Teratogens Antidotes Camptothecin Insecticides Carboplatin Methotrexate Taxoids Antibodies, Monoclonal Organoplatinum Compounds Plant Extracts Leucovorin Etoposide Glutathione Vinblastine Antineoplastic Agents, Alkylating Acetaminophen Antibiotics, Antineoplastic Contrast Media Xenobiotics Vincristine Pesticides Radiopharmaceuticals Methylmercury Compounds Carcinogens Antibodies, Monoclonal, Humanized Aluminum Recombinant Proteins Cadmium Prodrugs Drug Combinations Antioxidants Neurotoxins Ifosfamide Dacarbazine Benzene Metals, Heavy Drug Carriers Lead Mutagens

Analytical, Diagnostic and Therapeutic Techniques and Equipment99

Toxicity Tests Risk Assessment Toxicity Tests, Acute Treatment Outcome Reproducibility of Results Lethal Dose 50 Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Prospective Studies Geriatric Assessment Sensitivity and Specificity Questionnaires Observer Variation Nutrition Assessment Severity of Illness Index Follow-Up Studies No-Observed-Adverse-Effect Level Infusions, Intravenous Administration, Oral Predictive Value of Tests Feasibility Studies Retrospective Studies Pilot Projects Combined Modality Therapy Risk Factors Maximum Tolerated Dose Survival Analysis Animal Testing Alternatives Drug Evaluation Prognosis Drug Evaluation, Preclinical Survival Rate Magnetic Resonance Imaging Analysis of Variance Disease-Free Survival Cohort Studies Body Weight Area Under Curve Clinical Trials as Topic Research Design Tomography, X-Ray Computed Toxicity Tests, Subchronic Disease Models, Animal Radiotherapy Dosage Cross-Sectional Studies Organ Size Neoplasm Staging Statistics, Nonparametric Pain Measurement Models, Biological Disability Evaluation Evaluation Studies as Topic Radiotherapy Reference Values Activities of Daily Living Double-Blind Method Longitudinal Studies Health Impact Assessment Injections, Intravenous Regression Analysis ROC Curve Mutagenicity Tests Remission Induction Randomized Controlled Trials as Topic Drug Therapy, Combination Linear Models Dose Fractionation Physical Examination Health Status Indicators Data Collection Case-Control Studies Radiotherapy, Conformal Models, Theoretical Carcinogenicity Tests Biological Assay Toxicity Tests, Subacute Imaging, Three-Dimensional Models, Statistical Clinical Trials, Phase I as Topic Salvage Therapy Random Allocation Prevalence Preoperative Care Radioimmunotherapy Multivariate Analysis Program Evaluation Chemotherapy, Adjuvant Drug Delivery Systems Hematologic Tests Symptom Assessment Logistic Models Chi-Square Distribution Data Interpretation, Statistical Drug Carriers Probability Metabolic Clearance Rate Positron-Emission Tomography Patient Selection

Psychiatry and Psychology6

Psychometrics Personality Assessment Neuropsychological Tests Pain Cognition Disorders Psychiatric Status Rating Scales

Phenomena and Processes26

Dose-Response Relationship, Drug Time Factors Lethal Dose 50 Sensitivity and Specificity No-Observed-Adverse-Effect Level Cell Survival Maximum Tolerated Dose Pregnancy Body Weight Area Under Curve Algorithms Organ Size Drug Interactions Tissue Distribution Oxidative Stress Pain Apoptosis Particle Size Drug Synergism Mutation Biotransformation Cell Death Species Specificity Chi-Square Distribution Probability Metabolic Clearance Rate

Disciplines and Occupations6

Outcome Assessment (Health Care)Toxicology Research Design Ecotoxicology Toxicogenetics Environmental Health

Anthropology, Education, Sociology and Social Phenomena10

Geriatric Assessment Needs Assessment Educational Measurement Quality of Life Clinical Competence United States Environmental Protection Agency Activities of Daily Living Education, Pharmacy Health Status Curriculum

Technology, Industry, Agriculture3

Quality Control Nanoparticles Metal Nanoparticles

Humanities1

Quality of Life

Information Science10

Geriatric Assessment Questionnaires Survival Rate Algorithms Data Collection Image Processing, Computer-Assisted Radiotherapy, Conformal Imaging, Three-Dimensional Prevalence Data Interpretation, Statistical

Named Groups1

Infant, Newborn

Health Care71

Risk Assessment Treatment Outcome Reproducibility of Results Nursing Assessment Outcome Assessment (Health Care)Prospective Studies Geriatric Assessment Sensitivity and Specificity Needs Assessment Questionnaires Observer Variation Nutrition Assessment Severity of Illness Index Follow-Up Studies Predictive Value of Tests Feasibility Studies Retrospective Studies Pilot Projects Risk Factors Technology Assessment, Biomedical Environmental Monitoring Survival Analysis Radiation Injuries Environmental Exposure Survival Rate Analysis of Variance Disease-Free Survival Clinical Competence Cohort Studies Area Under Curve Clinical Trials as Topic Cross-Sectional Studies United States Environmental Protection Agency Age Factors Outcome and Process Assessment (Health Care)Statistics, Nonparametric Occupational Exposure Evaluation Studies as Topic Activities of Daily Living Double-Blind Method Longitudinal Studies Health Impact Assessment Regression Analysis ROC Curve Inhalation Exposure Process Assessment (Health Care)Randomized Controlled Trials as Topic Linear Models Health Status Indicators Data Collection Case-Control Studies Safety Quality Assurance, Health Care Patient Satisfaction Models, Statistical Clinical Trials, Phase I as Topic Practice Guidelines as Topic Random Allocation Prevalence Preoperative Care Sex Factors Health Status Multivariate Analysis Program Evaluation Guidelines as Topic Logistic Models Chi-Square Distribution Data Interpretation, Statistical Probability Maximum Allowable Concentration Patient Selection

Geographicals2

United States Great Britain

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Toxicity Tests Risk Assessment Toxicity Tests, Acute Treatment Outcome Reproducibility of Results Dose-Response Relationship, Drug Time Factors Nursing Assessment Lethal Dose 50 Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Outcome Assessment (Health Care)Toxicity Tests, Chronic Antineoplastic Agents Prospective Studies Geriatric Assessment Neoplasms Sensitivity and Specificity Needs Assessment Questionnaires Observer Variation Nutrition Assessment Severity of Illness Index Follow-Up Studies Toxicology No-Observed-Adverse-Effect Level Infusions, Intravenous Administration, Oral Predictive Value of Tests Feasibility Studies Cisplatin Retrospective Studies Cell Survival Pilot Projects Combined Modality Therapy Fluorouracil Drug-Related Side Effects and Adverse Reactions Risk Factors Maximum Tolerated Dose Educational Measurement Environmental Pollutants Technology Assessment, Biomedical Quality of Life Environmental Monitoring Survival Analysis Doxorubicin Liver Water Pollutants, Chemical Animal Testing Alternatives Radiation Injuries Drug Evaluation Prognosis Drug Evaluation, Preclinical Deoxycytidine Lung Neoplasms Antineoplastic Agents, Phytogenic Environmental Exposure United States Biological Markers Survival Rate Magnetic Resonance Imaging Breast Neoplasms Leukopenia Drug-Induced Liver Injury Paclitaxel Antimetabolites, Antineoplastic Hazardous Substances Pregnancy Analysis of Variance Disease-Free Survival Psychometrics Clinical Competence Cohort Studies Body Weight Area Under Curve Cyclophosphamide Rats, Sprague-Dawley Neutropenia Disease Progression Teratogens Clinical Trials as Topic Research Design Tomography, X-Ray Computed Antidotes Camptothecin Toxicity Tests, Subchronic Insecticides Disease Models, Animal Algorithms Radiotherapy Dosage Cross-Sectional Studies Organ Size Neoplasm Staging United States Environmental Protection Agency Age Factors Outcome and Process Assessment (Health Care)Carboplatin Hematologic Diseases Drug Interactions Personality Assessment

No FAQ available that match "assessment and toxicity"